GetTopicDetailResponse(id=feb91616605, topicName=Servier, introduction=Servier, content=null, image=null, comments=2, allHits=682, url=https://h5.medsci.cn/topic?id=16166, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=79962, tagList=[TagDto(tagId=79962, tagName=Servier)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1793753, encodeId=cce31e9375321, content=<a href='/topic/show?id=feb91616605' target=_blank style='color:#2F92EE;'>#Servier#</a>, objectTitle=Allogene與Servier宣布FDA批準ALLO-501的IND, objectType=article, longId=159163, objectId=daa71591634d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daa71591634d, replyNumber=0, likeNumber=70, createdTime=2019-03-14, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daa71591634d, moduleTitle=Allogene與Servier宣布FDA批準ALLO-501的IND, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=daa71591634d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793752, encodeId=86031e937527a, content=<a href='/topic/show?id=feb91616605' target=_blank style='color:#2F92EE;'>#Servier#</a>, objectTitle=法國第二大制藥公司施維雅（Servier）24億美元收購Shire公司的腫瘤業(yè)務經(jīng)營權, objectType=article, longId=147989, objectId=442014e9890d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=442014e9890d, replyNumber=0, likeNumber=84, createdTime=2019-04-17, rootId=0, userName=makuansheng, userId=2ba9118, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=442014e9890d, moduleTitle=法國第二大制藥公司施維雅（Servier）24億美元收購Shire公司的腫瘤業(yè)務經(jīng)營權, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=442014e9890d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
